Differences

This shows you the differences between two versions of the page.

--- scott_klarenbach [2022/10/25 07:01]
liam
+++ scott_klarenbach [2022/10/26 23:16] (current)
liam
@@ Line 3: / Line 3: @@
 {{ ::scottklarenbach.jpeg?200|}}
-Dr. **Scott Klarenbach**, MD, MSc, FRCPC is a Canadian nephrologist.
+Dr. **Scott Klarenbach**, MD, MSc, FRCPC is a Canadian nephrologist. He is co-chair of the [[AHS COVID-19 Scientific Advisory Group]] under [[Alberta Health Services]].
 ===== Education =====
@@ Line 24: / Line 24: @@
 === Real-World Evidence Consortium ===
-Klarenbach is Director of the [[Real-World Evidence Consortium]] at the [[University of Calgary]], which conducts pharmacoepidemiologic and pharmacoeconomic research.((Klarenbach, S. (2022, May 12). //Disclosure Form.// Canadian Task Force on Preventative Health Care. https://web.archive.org/web/20221025043248/https://canadiantaskforce.ca/wp-content/uploads/2022/06/Disclosure-June2022-Klarenbach.pdf)) In his declaration of interest from June 2022, Klarenbach noted that the success of RWEC "is contingent on industry funding", though he doesn't receive any honoraria himself.
+Klarenbach is Director of the [[Alberta Real-World Evidence Consortium]] at the [[University of Calgary]], which conducts pharmacoepidemiologic and pharmacoeconomic research.((Klarenbach, S. (2022, May 12). //Disclosure Form.// Canadian Task Force on Preventative Health Care. https://web.archive.org/web/20221025043248/https://canadiantaskforce.ca/wp-content/uploads/2022/06/Disclosure-June2022-Klarenbach.pdf)) In his declaration of interest from June 2022, Klarenbach noted that the success of RWEC "is contingent on industry funding", though he doesn't receive any honoraria himself.
 ==== Research ====
 Klarenbach has published research funded by the [[Public Health Agency of Canada]] through the [[Jewish General Hospital]].((Beck, A., Persaud, N., Tessier, L. A., Grad, R., Kidd, M. R., Klarenbach, S., Korownyk, C., Moore, A., Thombs, B. D., Mangin, D., McCracken, R. K., McDonald, E. G., Sirois, C., Kanji, S., Molnar, F., Nicholls, S. G., Thavorn, K., Bennett, A., Shaver, N., & Skidmore, B. (2022). //Interventions to address potentially inappropriate prescriptions and over-the-counter medication use among adults 65 years and older in primary care settings: protocol for a systematic review.// Systematic Reviews, 11(1). https://doi.org/10.1186/s13643-022-02044-w))
+Additional grants involving Klarenbach as Principal or co-Principal Investigator have come from:((//Profile | Dr. Scott Klarenbach.// University of Alberta. Retrieved October 25, 2022, from https://web.archive.org/web/20221025045508/https://www.ualberta.ca/medicine/about/people/details.html?n=scott-klarenbach#Grants))
+  * [[Alberta Health Services]] (AHS)
+  * [[Alberta Innovates]]
+  * [[Canadian Agency for Drugs and Technology in Health]] (CADTH)
+  * [[Canadian Institutes of Health Research]] (CIHR)
+  * [[Institute of Health Economics]] (IHE)
+  * [[Interdisciplinary Chronic Disease Collaboration]] (ICDC)
+  * [[Kidney Health Research Group]] (KHRG)
+  * [[Lawson Health Research Institute]]
+  * [[University Hospital Foundation]] (UHF)